I would like to receive updates and special offers from Dow Jones and affiliates. I can unsubscribe at any time.

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...

Personal healthcare products provider Kenvue Inc. (NYSE:KVUE) has been in the news for one reason or another recently.

A month after claiming a link between Tylenol use and autism, Health Secretary Robert F. Kennedy Jr. now says there's 'not ...

Consumer giant Kimberly-Clark has agreed to buy Kenvue, the parent company of embattled brand Tylenol, for nearly $49 billion. But what does this mean for consumers and shareholders?

The merger will bring together brands such as Huggies, Kleenex, Aveeno, and Tylenol, with Kimberly-Clark shareholders set to ...

A £30 billion takeover shakes up the consumer health sector as Kimberly-Clark, the maker of Huggies nappies, prepares to ...

There’s a whole list of alternative tariffs the administration could deploy— but they might require investigations, include ...

Parents deserve honest, evidence-based communication that acknowledges the many factors that contribute to a given child’s ...

The record dropped the same week that Pope John Paul II and Palestine leader Yasser Arafat came together for their historic ...

The Kimberly-Clark/Kenvue transaction is one of the worst-received major merger deals in recent years. Investors wondered why Kimberly-Clark was willing to buy a company with weakening sales and ...

Sadaf Faisal, senior director of professional affairs at the Canadian Pharmacists Association, said the codeine-containing medications such as Tylenol 3 are back in stock. Supply is still limited for ...